Annual report pursuant to Section 13 and 15(d)

Intangible Assets (Tables)

v3.10.0.1
Intangible Assets (Tables)
 12 Months Ended
Nov. 30, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets

Intangible assets were as follows as of November 30, 2018 and 2017:

 

     Useful lives      November 30, 2018      November 30, 2017  

Patents

      10-20 years      $ 234,570      $ 34,570  

Less: Accumulated amortization

         (23,663 )       (11,800 ) 

License agreement

      10 years        470,000        470,000  

Less: Intangible asset impairment

         (185,000 )       (185,000 ) 

Less: Accumulated amortization

         (123,528 )       (91,861 ) 

Customer relationships – Prepacyte®CB

      15 years        41,000        41,000  

 

Less: Intangible asset impairment

         (26,267 )       (26,267 ) 

Less: Accumulated amortization

         (5,276 )       (4,224 ) 

Brand

    1 year      31,000        —    

Less: Accumulated amortization

         (15,500 )       —    

Customer relationships – Cord:Use

    30 years      960,000        —    

Less: Accumulated amortization

         (16,000 )       —    
     

 

 

     

 

 

  

Net Intangible Assets

    $ 1,341,336      $ 226,418  
     

 

 

     

 

 

  
Schedule of Expected Amortization Expenses

Expected amortization related to these intangible assets for each of the next five fiscal years and for periods thereafter is as follows:

Fiscal years ending November 30:

 

2019

    $ 92,081  

2020

    $ 76,343  

2021

    $ 76,343  

2022.

    $ 76,343  

2023

    $ 76,343  

Thereafter

    $ 943,883  
  

 

 

  

Total

    $ 1,341,336